Skip to main content
Journal of Thoracic Disease logoLink to Journal of Thoracic Disease
. 2019 Mar;11(3):E63. doi: 10.21037/jtd.2019.02.96

Erratum to updated statistics of lung and bronchus cancer in United States (2018)

Gabrielle Boloker 1, Cong Wang 1, Jianrong Zhang 1,
PMCID: PMC6462676  PMID: 31019804

Updated statistics of lung and bronchus cancer in United States (2018)

In the article that appeared on Page 1158-1161, Vol 10, No 3 (March 2018) Issue of the Journal of Thoracic Disease (JTD) (1), the number in the following sentence is based on the statistics for 2017, instead of the statistics for 2018. Here, we sincerely apologize for the mistakes.

“Based on the data from 2006 to 2012, the 5-year survival rate is still low: 55% in localized stage (white: 56%; black: 49%), 28% in regional stage (white: 28%; black: 25%), 4% in distant stage (white: 4%; black: 4%), and 18% in all stages (white: 18%; black: 15%)”.

Therefore, the correct sentence should have read as follows:

“Based on the data from 2006 to 2012, the 5-year survival rate is still low: 56% in localized stage (white: 56%; black: 51%), 29% in regional stage (white: 29%; black: 26%), 5% in distant stage (white: 4%; black: 4%), and 18% in all stages (white: 18%; black: 15%)”.

The authors regret the error.

References

  • 1.Boloker G, Wang C, Zhang J. Updated statistics of lung and bronchus cancer in United States (2018). J Thorac Dis 2018;10:1158-61. 10.21037/jtd.2018.03.15 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Thoracic Disease are provided here courtesy of AME Publications

RESOURCES